ANI Gains FDA Approval for Everolimus Oral Suspension Tablets
PRINCETON, N.J. — September 23, 2026 ANI Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted...
R&D
Advertisement
Roche Opens Boston Innovation Center for CVRM Research
BASEL, Switzerland — September 17, 2026 Roche announced the grand opening of the Roche Genentech Innovation Center Boston, expanding...
Amneal Completes Kashiv BioSciences Acquisition to Expand Biosimilars
Bridgewater, N.J., August 10, 2026 Amneal Pharmaceuticals, Inc. has completed its acquisition of Kashiv BioSciences, LLC, creating a scaled,...
Asimov Completes Biosimilar Antibody Cell Line Campaign with Kyungdong
Boston, MA, August 9, 2026 Asimov announced the successful completion of a cell line development campaign in collaboration with...
Advertisement
